(Q37216689)

19 August 2017

1 reference

title

Validation criteria for panic disorder as a nosological entity (English)

1 reference

19 August 2017

0 references

R. Rosenberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862735

12 December 2022

J. O. Ottosson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862735

12 December 2022

P. Bech

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862735

12 December 2022

M. Mellergård

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862735

12 December 2022

N. K. Rosenberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1862735

12 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1862735

12 December 2022

publication date

1 January 1991

1 reference

full work available at URL

19 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1991.tb03096.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0447.1991.tb03096.x/fullpdf

12 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Acta psychiatrica Scandinavica. Supplementum

12 December 2022

published in

1 reference

19 August 2017

365

1 reference

19 August 2017

7-17

1 reference

The classification of phobic disorders

19 August 2017

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.

12 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

12 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

12 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research

12 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Recent developments in the treatment of panic disorder.

12 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

12 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Current concepts in psychiatry. Panic attacks and phobias

12 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The diagnostic validity of anxiety disorders and their relationship to depressive illness

12 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Anxiety, panic and phobic disorders: an overview

12 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Aetiology and mechanisms of anxiety disorders

12 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The epidemiology of anxiety disorders: rates, risks and familial patterns

12 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The incidence of specific DIS/DSM-III mental disorders: data from the NIMH Epidemiologic Catchment Area Program

12 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Relationship between panic disorder and agoraphobia. A family study

12 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Major depression in patients with agoraphobia and panic disorder

12 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Three cases of panic disorder with agoraphobia in children

12 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Quality of life in panic disorder.

12 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Excess mortality in panic disorder. A comparison with primary unipolar depression.

12 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Use of mental health services for the treatment of panic disorder.

12 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Prodromal symptoms in panic disorder with agoraphobia.

12 December 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Onset of panic disorder with agoraphobia. Toward an integrated model.

12 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Prevalence of traumatic early life events in 31 agoraphobic patients with panic attacks

12 December 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Life events and the onset of panic disorder.

12 December 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Recent life events and panic disorder.

12 December 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The relationship of anxiety and depression: a review of the literature

12 December 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Clinical and psychobiological characteristics of simultaneous panic disorder and major depression

12 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

British Journal of Psychiatry

12 December 2022

40

author name string

Second phase investigators, cross-national collaborative panic study

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Anxiety disorders: A long-term prospective and retrospective follow-up study of former inpatients suffering from an anxiety neurosis or phobia

12 December 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

12 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Major depression, anxiety disorders and mixed conditions. Childhood and precipitating events

12 December 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.

12 December 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

12 December 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Panic disorder and major depression. Increased risk of depression, alcoholism, panic, and phobic disorders in families of depressed probands with panic disorder.

12 December 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Simultaneous panic and depressive disorders: clinical and sleep EEG correlates.

12 December 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Platelet imipramine binding in patients with panic disorder and major familial depression.

12 December 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Situational panic attacks. Behavioral, physiologic, and biochemical characterization.

12 December 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The corticotropin-releasing hormone stimulation test in patients with panic disorder.

12 December 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Reduced TSH and prolactin responses to TRH in patients with panic disorder.

12 December 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls.

12 December 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The dexamethasone suppression test in agoraphobia.

12 December 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

HPA axis disturbance and treatment outcome in panic disorder.

12 December 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Early separation anxiety and adult agoraphobia

12 December 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Case histories and shorter communications. Agoraphobia: a test of the separation anxiety hypothesis.

12 December 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Relationships between panic disorder and separation anxiety with school phobia.

12 December 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

DSM-III personality disorders and the outcome of treated panic disorder.

12 December 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

State and personality in depressed and panic patients.

12 December 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

DSM-III personality disorder in agoraphobia. II. Changes with treatment

12 December 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Level of ego development and psychotherapy outcome in phobic patients

12 December 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Anxiety disorders: a comparison of the ICD-9 and DSM-III-R classification systems

12 December 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Panic disorder and medical illness.

12 December 2022

66

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A family study of panic disorder.

12 December 2022

68

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A family study of generalized anxiety disorder.

12 December 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Genetic factors in anxiety disorders.

12 December 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A linkage study of panic disorder

12 December 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Lactate Metabolism in Anxiety Neurosis

12 December 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Lactate infusions and panic attacks: do patients and controls respond differently?

12 December 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates

12 December 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

CO2 challenge of patients with panic disorder.

12 December 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

12 December 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Increased anxiogenic effects of caffeine in panic disorders

12 December 2022

82

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A comparison of lactate and isoproterenol anxiety states.

12 December 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A benzodiazepine receptor-mediated model of anxiety. Studies in nonhuman primates and clinical implications.

12 December 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

The application of positron emission tomography to the study of panic disorder.

12 December 2022

85

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Neuroanatomical correlates of a lactate-induced anxiety attack

12 December 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Neuroanatomical correlates of anticipatory anxiety.

12 December 2022

87

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients

12 December 2022

88

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Platelet monoamine oxidase activity in patients with panic disorder.

12 December 2022

89

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Platelet serotonin uptake in panic disorder.

12 December 2022

90

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder

12 December 2022

91

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.

12 December 2022

92

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.

12 December 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.

12 December 2022

94

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

12 December 2022

95

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

12 December 2022

96

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

12 December 2022

98

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

12 December 2022

99

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Lack of efficacy of carbamazepine in the treatment of panic disorder.

12 December 2022

103

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A neuroanatomical hypothesis for panic disorder

12 December 2022

104

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Follow-up of agoraphobic patients treated with exposure in vivo or applied relaxation.

12 December 2022

108

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Agoraphobics 5 years after imipramine and exposure. Outcome and predictors

12 December 2022

109

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Applied relaxation vs progressive relaxation in the treatment of panic disorder.

12 December 2022

111

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A cognitive approach to panic.

12 December 2022

112

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Dyspneic-fear and catastrophic cognitions in hyperventilatory panic attacks

12 December 2022

113

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Psychiatric reaction patterns to imipramine

12 December 2022

118

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

12 December 2022

119

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Are there Anticompulsive or Antiphobic Drugs? Review of the Evidence

12 December 2022

122

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.

12 December 2022

125

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety

12 December 2022

126

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Two-year follow-up of exposure and imipramine treatment of agoraphobia

12 December 2022

127

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Agoraphobia: the long-term follow-up of behavioural treatment.

12 December 2022

128

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Respiratory control as a treatment for panic attacks.

12 December 2022

129

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

Experimental analyses of panic--III. Claustrophobic subjects

12 December 2022

130

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1991.TB03096.X

12 December 2022

Identifiers

0 references

1 reference